Saunders Scott J 4

What Happened
Scott J. Saunders, a director of Nutex Health, was granted 823 restricted stock units (RSUs) on April 23, 2026. The grant is reported at $0.00 per unit (no cash paid at grant); the RSUs are derivative awards that represent a contingent right to receive one share of Nutex Health common stock upon vesting.

Key Details

• Transaction date: April 23, 2026; Form 4 filed April 24, 2026 (timely filing).
• Award: 823 RSUs granted; grant price reported as $0.00; total reported immediate value $0.
• Vesting: 100% vests on April 23, 2027 (per footnote). If Saunders leaves without cause during the vesting period, RSUs vest pro‑rata for actual service time.
• Shares owned after transaction: not specified in the filing.
• Filing type: Award/Grant (derivative); not a purchase or sale of shares.

Context
RSUs are a form of equity compensation that convert into actual shares upon vesting. This grant does not involve an immediate cash purchase or sale and does not by itself indicate a buy/sell signal. The award simply grants the right to receive common shares in the future subject to the stated vesting conditions.